Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0214 | 0.4243 | 0.5 | |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0257 | 0.5874 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0102 | 0 | 0.5 |
Brugia malayi | dihydrofolate reductase family protein | 0.0257 | 0.5874 | 1 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0367 | 1 | 0.5 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0367 | 1 | 0.5 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0257 | 0.5874 | 1 |
Echinococcus granulosus | dihydrofolate reductase | 0.0257 | 0.5874 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0214 | 0.4243 | 0.7223 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0367 | 1 | 0.5 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0257 | 0.5874 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0367 | 1 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.0257 | 0.5874 | 1 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0257 | 0.5874 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0257 | 0.5874 | 1 |
Brugia malayi | thymidylate synthase | 0.0214 | 0.4243 | 0.7223 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0257 | 0.5874 | 0.5 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0367 | 1 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0257 | 0.5874 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MCC (functional) | > 80 ug ml-1 | Minimal cytotoxic concentration(MCC) to cause a microscopically detectable change in normal cell morphology | ChEMBL. | 11708929 |
MIC (functional) | = 0.005 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against KOS strain of human Herpes Simplex Virus -1 | ChEMBL. | 11708929 |
MIC (functional) | = 0.005 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against F strain of human Herpes Simplex Virus-1 (HSV-1) | ChEMBL. | 11708929 |
MIC (functional) | = 0.005 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against McIntyre strain of human Herpes Simplex Virus-1 | ChEMBL. | 11708929 |
MIC (functional) | = 0.02 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against Lyons strain of human Herpes Simplex Virus-2 | ChEMBL. | 11708929 |
MIC (functional) | = 0.03 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against G strain of human Herpes Simplex Virus-2 | ChEMBL. | 11708929 |
MIC (functional) | = 0.04 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against TK-/TK+ HSV-1 of VMW 837 | ChEMBL. | 11708929 |
MIC (functional) | = 0.08 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against 196 strain of human Herpes Simplex Virus-2 | ChEMBL. | 11708929 |
MIC (functional) | > 16 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against Thymidine kinase deficient(TK-) HSV-1 of Acyclovir | ChEMBL. | 11708929 |
MIC (functional) | > 80 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against VV | ChEMBL. | 11708929 |
MIC (functional) | > 80 ug ml-1 | Minimal inhibitory concentration to reduce virus-induced cytopathicity against VSV | ChEMBL. | 11708929 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.